Unilife Corp. (NASDAQ:UNIS) had its target price boosted by Cantor Fitzgerald from $6.00 to $8.00 in a report issued on Tuesday, American Banking News.com reports.
Separately, analysts at Ladenburg Thalmann raised their price target on shares of Unilife Corp. from $4.50 to $6.50 in a research note to investors on Friday, November 22nd. They now have a buy rating on the stock.
Shares of Unilife Corp. (NASDAQ:UNIS) traded down 1.03% on Tuesday, hitting $4.79. The stock had a trading volume of 4,303,664 shares. Unilife Corp. has a one year low of $1.80 and a one year high of $5.10. The stock has a 50-day moving average of $3.40 and a 200-day moving average of $3.2. The company’s market cap is $468.4 million.
Unilife Corp. (NASDAQ:UNIS) last released its earnings data on Monday, November 11th. The company reported ($0.12) EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.60 by $1.72. The company had revenue of $3.20 million for the quarter, compared to the consensus estimate of $5.80 million. During the same quarter in the prior year, the company posted ($0.21) earnings per share. Analysts expect that Unilife Corp. will post $-0.32 EPS for the current fiscal year.
Unilife Corporation (NASDAQ:UNIS) is a developer and commercial supplier injectable drug delivery systems.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.